Promise Advanced Proteomics was created in 2010 and is now the Innovation diagnostics subsidiary of the Aguettant pharmaceutical group.

Promise proteomics has developed innovative mass spectrometry-based technologies to address protein absolute quantification in biological samples.

Capitalising on its unique know-how in the production of internal standards for protein assays and its recognised expertise in mass spectrometry-based quantification methods, Promise Proteomics is placing its skills at the service of Biologist and clinicians through its mAbXmise kits : the next generation of biotherapy monitoring.

mAbXmise kits are designed to be ready to use, easy-to-handle and allows optimal reliability and accuracy using mass spectrometry.


Headquartered in Bethlehem, PA, Saladax Biomedical, Inc. is a privately held company that develops, manufactures, and markets assays that provide rapid therapeutic drug levels for essential and life-saving medicines prescribed by psychiatrists and oncologists. Since 2007, Saladax’s proprietary technology has been used in clinical laboratories or point-of-care settings to assist clinicians monitor and optimize patient care. Additionally, the company collaborates with leading pharmaceutical companies to develop tests for clinical trials and companion diagnostics. For more information, visit MyCareTests.com


As a leading clinical LC-MS/MS solutions partner, Waters is a trusted provider of in vitro diagnostic medical devices, consumables, informatics, and support services for high performance LC-MS/MS systems. At Waters™, we understand that Clinical Diagnostics is more than collecting data. It’s making a difference in someone’s life. We know that behind every test tube you handle, and analytical instrument you operate, is a person that you help. We realize that when you analyze these samples, you are transforming data into better care. Because in the end, every piece of information is a part of an explanation, and every sample is a life. That’s why we provide clinical solutions that you can trust every step of the way.


At Siemens Healthineers, our purpose is to enable healthcare providers to increase value by empowering them on their journey toward expanding precision medicine, transforming
care delivery, and improving patient experience, all made possible by digitalizing healthcare.
An estimated 5 million patients globally benefit every day from our innovative technologies and services in the areas of diagnostic and therapeutic imaging, laboratory diagnostics, and molecular
medicine, as well as digital health and enterprise services. We are a leading medical technology company with over 120 years of experience and 18,000 patents globally. Through the dedication
of more than 50,000 colleagues in 75 countries, we will continue to innovate and shape the future of healthcare.

ARK Diagnostics, Inc.

ARK Diagnostics, Inc. designs, develops, manufactures, and distributes in vitro diagnostic (IVD) immunoassays for therapeutic drug monitoring (TDM), urine drug testing (UDT), and veterinary testing. ARK’s proprietary assays accurately measure drug levels in biological fluids. Its highly regarded homogeneous enzyme immunoassay technology is adaptable to a wide variety of automated clinical chemistry analyzers.


CoQua Lab s.r.l. (Compound Quantification Laboratory) is an innovative startup founded in 2015 as an accademic spin-off of the University of Turin wich develop analitical methods and diagnostic kit CE-IVD in the clinical field. The many years of experience of all the founders in pharmacological and clinical R&D gave rise to the idea of CoQua Lab: a research and developing laboratory, born to serve the biomedical progress.


Abbott understands that the first step to living your best life is good health. Everything Abbott makes is designed to help you do just that. That’s the company’s commitment to building life-changing technologies that keep your heart healthy, nourish your body at every stage of life, help clients feel and move better, and bring them information, medicines, and breakthroughs to manage their health.

B.S.N Srl

B.S.N. srl was founded in 1994 in Castelleone (Italy) as distributor of in-vitro diagnostics and high technology medical devices into Italian territory.
More recently, B.S.N. established a division for research, development and production of diagnostic kit based on chromatographic methods as HPLC and LC-MS/MS.
We have already developed and released some innovative and unique diagnostic kits for the measurement of biomarkers and drugs in various medicine branches as Nephrology, Endocrinology, Toxicology and Oncology.
Our company motto “TECNOLOGIA, COMPETENZA, SERVIZIO” (i.e. technology, skills, assistance) interprets our way of working. The goal is to support the clinical lab needs from the very first steps to the post sales assistance, thanks to our highly qualified team of application specialists, researchers and service engineers.

Randox Toxicology

Randox has over 35 years’ experience in the diagnostic market with a heavy focus on R&D, and is dedicated to advancing forensic, clinical and workplace toxicology. This focus has led to the development of technology, which is at the forefront of advanced global diagnostics, and trusted by market leaders to deliver accurate and reliable results.

Randox Toxicology is a market leader in the development of new assays and technology in the field of toxicology, aiming to minimise laboratory workflow constraints whilst maximising the scope of quality drug detection. We are the primary manufacturer of Biochip Array Technology and ELISAs for forensic, clinical and workplace toxicology.


Quidel is a leading company in the production of point-of-care diagnostic solutions since 1979. We offer rapid test technologies capable of providing fast and accurate answers for a wide range of infectious diseases, cardiovascular and metabolic conditions. Our Triage TOX Drug Screen is a trusted companion of laboratory and ED professionals around the world.


BÜHLMANN is a Swiss In vitro diagnostics company, with global reach. BÜHLMANN was founded in 1976 and has since specialized in rapid tool diagnosis and monitoring of chronic inflammatory diseases. One major expertise is the Therapeutic Drug Monitoring of biological drugs to aid in efficient patient management and care.




Established on the diagnostics market for 30 years, Theradiag is now recognized as a key player in the development, manufacturing and marketing of innovative in-vitro diagnostic products, but also as a pioneer in Theranostic. This extensive experience in the field of diagnostics, combined with the reliability of our products and the performance of our customer service, enable us to address biologists as a high-quality partner with ISO 13 485 certifications.

Present in more than 70 countries, through its in vitro diagnostic activities and benefiting from strong growth in Theranostic, Theradiag brings together a whole range of unique and innovative skills to provide a personalized response to each of its customers, biologists, and clinicians. Theradiag is a leader in Theranostic and in the monitoring of autoimmune diseases, which is the third leading cause of morbidity in the world.

Download here the map with all exhibitors’ booths.